Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
4.890
+0.300 (6.54%)
Apr 1, 2026, 1:09 PM CET
Market Cap1.77B +153.8%
Revenue (ttm)839.00K
Net Income-58.01M
EPS-0.17
Shares Out361.38M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,190,785
Average Volume2,448,338
Open4.610
Previous Close4.590
Day's Range4.610 - 4.910
52-Week Range1.942 - 5.490
Beta-0.21
RSI57.85
Earnings DateAug 28, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 13
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements